CN102846740B - Navel-applied plaster for reducing high blood pressure caused by hyperactivity of liver-yang and preparation method thereof - Google Patents
Navel-applied plaster for reducing high blood pressure caused by hyperactivity of liver-yang and preparation method thereof Download PDFInfo
- Publication number
- CN102846740B CN102846740B CN201210307568.9A CN201210307568A CN102846740B CN 102846740 B CN102846740 B CN 102846740B CN 201210307568 A CN201210307568 A CN 201210307568A CN 102846740 B CN102846740 B CN 102846740B
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- radix
- liver
- vaseline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 22
- 206010020772 Hypertension Diseases 0.000 title abstract description 11
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 208000013403 hyperactivity Diseases 0.000 title abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 12
- 229940099259 vaseline Drugs 0.000 claims abstract description 12
- 238000001816 cooling Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 10
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 7
- 239000007766 cera flava Substances 0.000 claims description 7
- 230000036772 blood pressure Effects 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 230000000630 rising effect Effects 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 4
- 241001412627 Adenophora liliifolia Species 0.000 abstract 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 2
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 2
- 240000001851 Artemisia dracunculus Species 0.000 abstract 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 2
- 241000723353 Chrysanthemum Species 0.000 abstract 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 2
- 241000112528 Ligusticum striatum Species 0.000 abstract 2
- 239000001138 artemisia absinthium Substances 0.000 abstract 2
- 235000013871 bee wax Nutrition 0.000 abstract 2
- 239000012166 beeswax Substances 0.000 abstract 2
- 238000002844 melting Methods 0.000 abstract 2
- 230000008018 melting Effects 0.000 abstract 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 description 11
- 231100000869 headache Toxicity 0.000 description 11
- 230000035487 diastolic blood pressure Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 230000035488 systolic blood pressure Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- -1 excited Chemical compound 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A navel-applied plaster for reducing high blood pressure caused by hyperactivity of liver-yang provided by the invention comprises the following components, by weight: bulk medicines comprising 100-140 parts of chrysanthemum, 120-180 parts of Radix Paeoniae Alba, 80-120 parts of Ligusticum wallichii, 150-200 parts of Cortex Moutan Radicis, 80-120 parts of the root of straight ladybell and 80-120 parts of oriental wormwood; and auxiliary comprising 305-440 parts of vaseline and 305-440 parts of beeswax. The preparation method of the navel-applied plaster comprises the following steps: a. mixing chrysanthemum, Radix Paeoniae Alba, Ligusticum wallichii, Cortex Moutan Radicis, the root of straight ladybell and oriental wormwood according to the weight ratio, and crushing the mixture into a powder of higher than 100 mesh; and b. melting vaseline of the above weight parts at 38-60 DEG C, adding beeswax of the above weight parts, heating to 62-67 DEG C until complete melting, adding the medicinal powder according to the weight, rapid stirring, and cooling.
Description
Technical field
The invention belongs to Chinese medicine external umbilica sticking plaster field, be specially a kind of liver-heat rise the headache feeling of fullness in the head, the vertigo and tinnitus that cause, excessive rising of liver-YANG blood pressure lowering umbilica sticking plaster of the symptoms such as vascular hypertension and preparation method thereof of curing mainly.
Background technology
Hypertension belongs to the categories such as Chinese medicine " dizzy, headache ", and with cardiopalmus, palpitation with a distress feeling, apoplexy close association, patient's the five internal organs deficiency, decline of either YIN or YANG.Deficiency of both QI and blood is the intrinsic factor of morbidity, simultaneously, due to eating and drinking without temperance, the extrinsic factor such as excited, life style is bad, causes deficiency of the kidney, deficiency of kidney yin, the moon sun not processed.The kidney failing to nourish the liver, liver is lost bar and reaches, dysfunction of the spleen in transportation, according to statistics, in hypertension, syndrome of upper hyperactivity of liver yang ratio accounts for 87.33%.The hypertensive medicine of western medicine is numerous, and its curative effect also obtains certainly.But, the erious adverse reaction of western medicine, drug withdrawal is easily recurred, satisfied not to the utmost to the improvement of patients ' life quality.
Summary of the invention
The object of this invention is to provide a kind of determined curative effect, have no side effect, the simple excessive rising of liver-YANG blood pressure lowering of technique umbilica sticking plaster and preparation method thereof.
Excessive rising of liver-YANG blood pressure lowering umbilica sticking plaster of the present invention is by the crude drug of following parts by weight: 100～140 parts of Flos Chrysanthemis, 120～180 parts of the Radix Paeoniae Albas, 80～120 parts of Rhizoma Chuanxiongs, 150～200 parts of Cortex Moutans, 80～120 parts of Radix Adenophorae (Radix Glehniae), 80～120 parts of Herba Artemisiae Scopariaes; Be equipped with adjuvant: 305～440 parts, 305～440 parts, vaseline, Cera Flava are made.
The preparation method of this umbilica sticking plaster comprises the following steps: a, Flos Chrysanthemi, the Radix Paeoniae Alba, Rhizoma Chuanxiong, Cortex Moutan, Radix Adenophorae (Radix Glehniae), Herba Artemisiae Scopariae are mixed according to described parts by weight, be ground into medicated powder more than 100 orders; B, the vaseline of described parts by weight is melted at 38 DEG C～60 DEG C, add the Cera Flava of described parts by weight, heat and completely after fusing, add the medicated powder of described parts by weight to 62 DEG C～67 DEG C, rapid stirring is even, cooling and get final product.。
Preferably, umbilica sticking plaster of the present invention can be by the crude drug of following parts by weight: 120 parts of Flos Chrysanthemis, 150 parts of the Radix Paeoniae Albas, 100 parts of Rhizoma Chuanxiongs, 180 parts of Cortex Moutans, 100 parts of Radix Adenophorae (Radix Glehniae), 100 parts of Herba Artemisiae Scopariaes; Be equipped with adjuvant: 375 parts, 375 parts, vaseline, Cera Flava are made.
Flos Chrysanthemi is refrigerant property wind-heat-dispersing medicinal, function dispelling wind heat, and clear the rank and file of outlaws, pathogenic fire reducing and removing toxic substances, cure mainly headache dizzy, and blood pressure is hyperfunction, nervous headache etc., also effect of favourable liver improving eyesight; The Radix Paeoniae Alba cures mainly pathogen stomachache, except arthralgia due to stagnation of blood, broken hard long-pending, cold and heat, hernia abdominal mass, pain relieving, diuresis, QI invigorating; Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping, for pacifying nerve, positive wind syndrome of head headache, lump in the abdomen stomachache, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia; Cortex Moutan heat clearing away, removing heat from blood, and blood, repercussive, controls the pathogenic heat attacking blood system in febrile diseases, sends out speckle, and infantile convulsion, tells, is defeated in battle, has blood in stool, hectic fever due to YIN-deficiency consumptive fever, amenorrhea ， mass in the abdomen, carbuncle and ulcer, flutters damage; Radix Adenophorae (Radix Glehniae) nourishing YIN and clearing away lung-heat, reinforcing stomach reg fluid, thirsty for lung-heat type cough, chronic cough expectorant blood, calentura Tianjin wound; Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis, jaundice eliminating, for jaundice, dysuria, eczema pruritus, infectious jaundice type hepatitis.All medicine compatibilities, heat clearing away suppressing the hyperactive liver, treatment liver-heat rise the headache feeling of fullness in the head, the vertigo and tinnitus that cause, vascular hypertension texts is remarkable.
The present invention makes umbilica sticking plaster by said medicine and uses; compared with prior art there is following characteristics: Cera Flava has effect of astringent therapy, granulation promoting, pain relieving, removing toxic substances; vaseline has water proofing property, is a kind of extraordinary moisturizing articles for use, the raw material of using for preparing medical ointment and skin care ointment.The substrate (adjuvant) that it adopts as umbilica sticking plaster, chemical stabilization, and this umbilica sticking plaster has the feature of principal agent high volatility, preparation technology is easy, be conducive to umbilicus penetrates and absorbs, especially to skin of umbilicus place without anaphylaxis, more have no side effect.In addition the bad toxic and side effects that can avoid some oral drugs to bring generations such as patient's liver kidneys.
Relevant clinical data is as follows: in 120 routine cases, oldest 60 years old, minimum 32 years old, be divided at random three groups every group 40 examples.Three groups of cases are Epidemiological Analysis difference not statistically significant by statistics at aspects such as ages, has comparability.All cases, all with reference to Western medicine diagnose standard, are made a definite diagnosis according to " new Chinese medicine guideline of clinical investigations " criterion of therapeutical effect of the Diagnosing Hypertension of WHO revision in 1999 and grade scale and the dialectical standard of syndrome of upper hyperactivity of liver yang and Ministry of Public Health issue in 1993.
Diagnostic criteria: ideal bp: systolic pressure < 120mmHg, diastolic pressure < 80mmHg; Normal arterial pressure: systolic pressure < 130mmHg, diastolic pressure < 85mmHg; Normal high limit: systolic pressure 130～139mmHg, diastolic pressure 85～89mmHg; 1 grade of hypertension: systolic pressure 140～159mmHg, diastolic pressure 90～99mmHg (subgroup: borderline hypertension, systolic pressure 140～149mmHg, diastolic pressure 90～94mmHg); 2 grades of hypertension: systolic pressure 160～179mmHg, diastolic pressure 100～109mmHg.The dialectical standard of syndrome of upper hyperactivity of liver yang: 1. dizzy.2. headache.3. flush.4. irritated irritability.5. bitter taste and thirsty.6. stringy pulse.7. constipation.Possessing above-mentioned 4 persons can distinguish as liver-Yang sthenia type.
Therapeutic Method: three groups of each 45 examples, accept respectively embodiment 1, embodiment 2, embodiment 3 umbilicus patch clinical treatments, external (stance) is affixed on umbilical part and changes once for 48 hours, and manifold card is taken a day off for six days.It within 30 days, is a course for the treatment of.
Criterion of therapeutical effect: effective: diastolic pressure decline > 10mmHg is also down to normal or more than decline > 20mmHg, dizzy, headache symptom disappears substantially, and other symptoms obviously alleviate; Effective: though diastolic pressure declines and do not reach 10mmHg and be down to the normal or 10～19mmHg that declines, dizzy, headache symptom disappears substantially, but have dizziness, headache when excited, press ascensional range to be no more than 150/95mmHg; Invalid: not reach above-mentioned curative effect person.
After three groups of case treatments, curative effect comparative statistics result is as follows:
| Group | Embodiment 1 | Embodiment 2 | Embodiment 3 |
| Number of cases | 40 | 40 | 40 |
| Effective (n%) | 12（30%） | 11（27.5%） | 11（27.5%） |
| Effectively (n%) | 23（57.5%） | 23（57.5%） | 22（55%） |
| Invalid (n%) | 5（12.5%） | 6（15%） | 7（17.5%） |
| Anaphylaxis (n%) | 0（0%） | 0 （0%） | 0 （0%） |
| Total effective rate (n%) | 87.5% | 85% | 82.5% |
Detailed description of the invention
The invention will be further described for embodiment plan given below; but can not be interpreted as it is limiting the scope of the invention; according to the present invention, content, to nonessential improvement and adjustment more of the present invention, still belongs to protection scope of the present invention to those skilled in the art.
Embodiment 1: get 120 grams of Flos Chrysanthemis, 150 grams of the Radix Paeoniae Albas, 100 grams of Rhizoma Chuanxiongs, 180 grams of Cortex Moutans, 100 grams of Radix Adenophorae (Radix Glehniae), 100 grams of Herba Artemisiae Scopariaes, mix after drying at 35 DEG C, grinding and processing becomes medicated powder more than 100 orders.
First 375 grams of vaseline are melted at 50 DEG C, add 375 grams of Cera Flavas, heat to 63 DEG C completely fusing after, add medicated powder, rapid stirring is even, cooling.
Cooled umbilica sticking plaster is inserted to ring size 2cm in 6cm × 7cm() the internal ring of non-woven fabrics umbilica sticking plaster cloth pad in, 1.5 grams of doses.8cm × 12cm compound membrane bag for the finished product processing is packed, and one pastes one bag.
Embodiment 2: get 100 grams of Flos Chrysanthemis, 120 grams of the Radix Paeoniae Albas, 80 grams of Rhizoma Chuanxiongs, 150 grams of Cortex Moutans, 80 grams of Radix Adenophorae (Radix Glehniae), 80 grams of Herba Artemisiae Scopariaes, mix after drying at 67 DEG C, grinding and processing becomes medicated powder more than 100 orders.
First 305 grams of vaseline are melted at 60 DEG C, add 305 grams of Cera Flavas, heat to 65 DEG C completely fusing after, add medicated powder, rapid stirring is even, cooling.
Cooled umbilica sticking plaster is inserted to 7cm × 8cm(internal ring and is of a size of 2.5cm) the internal ring of non-woven fabrics umbilica sticking plaster cloth pad in, dose is 3 grams.8cm × 12cm compound membrane bag for the finished product processing is packed, and one pastes one bag.
Embodiment 3: get 140 grams of Flos Chrysanthemis, 180 grams of the Radix Paeoniae Albas, 120 grams of Rhizoma Chuanxiongs, 200 grams of Cortex Moutans, 120 grams of Radix Adenophorae (Radix Glehniae), 120 grams of Herba Artemisiae Scopariaes, mix after drying at 50 DEG C, grinding and processing becomes medicated powder more than 100 orders.
First 440 grams of vaseline are melted at 38 DEG C, add 440 grams of Cera Flavas, heat to 62 DEG C completely fusing after, add medicated powder, rapid stirring is even, cooling.
Cooled umbilica sticking plaster is inserted to 7cm × 8cm(internal ring and is of a size of 2.5cm) the internal ring of non-woven fabrics umbilica sticking plaster cloth pad in, dose is 3.1 grams.8cm × 12cm compound membrane bag for the finished product processing is packed, and one pastes one bag.
Claims (3)
1. excessive rising of liver-YANG blood pressure lowering umbilica sticking plaster; It is characterized in that the crude drug by following parts by weight: 100～140 parts of Flos Chrysanthemis, 120～180 parts of the Radix Paeoniae Albas, 80～120 parts of Rhizoma Chuanxiongs, 150～200 parts of Cortex Moutans, 80～120 parts of Radix Adenophorae (Radix Glehniae), 80～120 parts of Herba Artemisiae Scopariaes; Be equipped with adjuvant: 305～440 parts, 305～440 parts, vaseline, Cera Flava are made.
2. umbilica sticking plaster according to claim 1, is characterized in that the crude drug by following parts by weight: 120 parts of Flos Chrysanthemis, 150 parts of the Radix Paeoniae Albas, 100 parts of Rhizoma Chuanxiongs, 180 parts of Cortex Moutans, 100 parts of Radix Adenophorae (Radix Glehniae), 100 parts of Herba Artemisiae Scopariaes; Be equipped with adjuvant: 375 parts, 375 parts, vaseline, Cera Flava are made.
3. a method of preparing umbilica sticking plaster described in claim 1, is characterized in that comprising the following steps:
A, Flos Chrysanthemi, the Radix Paeoniae Alba, Rhizoma Chuanxiong, Cortex Moutan, Radix Adenophorae (Radix Glehniae), Herba Artemisiae Scopariae are mixed according to described parts by weight, be ground into medicated powder more than 100 orders;
B, the vaseline of described parts by weight is melted at 38 DEG C～60 DEG C, add the Cera Flava of described parts by weight, heat and completely after fusing, add the medicated powder of described parts by weight to 62 DEG C～67 DEG C, rapid stirring is even, cooling and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210307568.9A CN102846740B (en) | 2012-08-28 | 2012-08-28 | Navel-applied plaster for reducing high blood pressure caused by hyperactivity of liver-yang and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210307568.9A CN102846740B (en) | 2012-08-28 | 2012-08-28 | Navel-applied plaster for reducing high blood pressure caused by hyperactivity of liver-yang and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102846740A CN102846740A (en) | 2013-01-02 |
| CN102846740B true CN102846740B (en) | 2014-09-17 |
Family
ID=47393985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210307568.9A Expired - Fee Related CN102846740B (en) | 2012-08-28 | 2012-08-28 | Navel-applied plaster for reducing high blood pressure caused by hyperactivity of liver-yang and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102846740B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152338A (en) * | 2006-09-25 | 2008-04-02 | 李一龙 | Anti-hypertension spray agent |
-
2012
- 2012-08-28 CN CN201210307568.9A patent/CN102846740B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152338A (en) * | 2006-09-25 | 2008-04-02 | 李一龙 | Anti-hypertension spray agent |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102846740A (en) | 2013-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102670915A (en) | Traditional Chinese medicine combination for treating hashimoto thyroiditis | |
| CN101954006B (en) | Chinese medicament for treating insomnia | |
| CN1872235A (en) | Muskiness acesodyne ointment of chasing wind, and preparation method | |
| CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
| CN102423393B (en) | Traditional Chinese medicinal composition for treating qi stagnation and blood stasis type primary dysmenorrhea | |
| CN102847109B (en) | Navel-applied plaster for treating dysmenorrhea and preparation method thereof | |
| CN102846739B (en) | Navel-applied plaster for treating hepatitis and preparation method thereof | |
| CN105535495A (en) | Chinese medicinal composition for treating esophageal cancer by reinforcing vital essence and strengthening primordial qi and preparation method | |
| CN101904939A (en) | Chinese herb medicine for treating senile metrorrhagia | |
| CN102846741B (en) | Navel-applied plaster for treating sequelae of hemiplegia and preparation method thereof | |
| CN102846740B (en) | Navel-applied plaster for reducing high blood pressure caused by hyperactivity of liver-yang and preparation method thereof | |
| CN104436145A (en) | Pharmaceutical composition for preventing and/or treating allergic rhinitis and allergic asthma | |
| CN102846779B (en) | Navel-applied plaster for reducing blood glucose and preparation method thereof | |
| CN101297954B (en) | Unbilical medicament for treating cough and preparation thereof | |
| CN102847105B (en) | Navel-applied plaster for treating diarrhea before dawn and preparation method thereof | |
| CN102846772B (en) | Navel-applied plaster for treating senile constipation and preparation method thereof | |
| CN102058681A (en) | Traditional Chinese medicine for treating protrusion of lumbar vertebral disc and waist and leg pain and preparation method thereof | |
| CN102727773A (en) | Traditional Chinese medicinal capsule for treating blood mucoviscidosis | |
| CN106620530A (en) | Cancer pain stick for treating cancer pain | |
| CN105213655A (en) | A kind of Chinese medicine composition of adjuvant treatment of acute cholecystitis | |
| CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection | |
| CN104666840A (en) | Medicine for treating hyperthyroidism and preparation method of medicine | |
| CN104524334A (en) | Traditional Chinese medicine composition for elder pneumonia in adjuvant therapy | |
| CN103599503A (en) | Medicine for treating critical diseases and preparation method thereof | |
| CN104189076A (en) | Traditional Chinese medicine patch for treating juvenile bronchial asthma and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: QINGDAO MUNICIPAL HOSPITAL Free format text: FORMER OWNER: ZHAO AILIANG Effective date: 20140730 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Sun Xia Inventor after: Sun Hong Inventor after: Wang Qian Inventor after: Yi Wei Inventor before: Zhao Ailiang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHAO AILIANG TO: SUN XIA SUN HONG WANG QIAN YI WEI Free format text: CORRECT: ADDRESS; FROM: 047500 CHANGZHI, SHAANXI PROVINCE TO: 266011 QINGDAO, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140730 Address after: 266011 No. 5 Donghai Middle Road, Shandong, Qingdao Applicant after: Qingdao Municipal Hospital Address before: The street lane 047500 Shanxi province Caimao Changzhi Lucheng City No. 3 Applicant before: Zhao Ailiang |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140917 Termination date: 20160828 |